EUROFINS SCIENT Property, Plant, and Equipment 2018-2024 | ERFSF
EUROFINS SCIENT property, plant, and equipment from 2018 to 2024. Property, plant, and equipment can be defined as the sum of all net property, plant & Equipment fields. Where companies do not report a break down of plant, property, & equipment, the value is entered in this field alone.
- EUROFINS SCIENT property, plant, and equipment for the quarter ending June 30, 2024 was $0M, a 100% decline year-over-year.
- EUROFINS SCIENT property, plant, and equipment for 2023 was $2.486B, a 8.87% increase from 2022.
- EUROFINS SCIENT property, plant, and equipment for 2022 was $2.284B, a 5.49% increase from 2021.
- EUROFINS SCIENT property, plant, and equipment for 2021 was $2.165B, a 20.34% increase from 2020.
| EUROFINS SCIENT Annual Property, Plant, and Equipment (Millions of US $) |
|
|---|---|
| 2023 | $2,486 |
| 2022 | $2,284 |
| 2021 | $2,165 |
| 2020 | $1,799 |
| 2019 | $1,785 |
| 2018 | $1,202 |
| 2017 | $775 |
| 2016 | $0 |
| 2015 | $0 |
| EUROFINS SCIENT Quarterly Property, Plant, and Equipment (Millions of US $) |
|
|---|---|
| 2023-06-30 | |
| 2022-12-31 | $4,991 |
| 2021-12-31 | $4,757 |
| 2021-06-30 | |
| 2020-12-31 | $3,821 |
| 2020-06-30 | |
| 2019-12-31 | $3,552 |
| 2019-06-30 | |
| 2018-12-31 | $2,541 |
| 2018-06-30 | |
| 2017-12-31 | $1,878 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $12.351B | $7.522B |
| Eurofins Scientific SE provides testing services. The company provides food and feed testing, bioanalytical, biopharma, pharma discovery, pharma early development, pharma central laboratory, biopharma product testing, genomic, agroscience, consumer product testing, forensic, environment testing and REACH services. It operates primarily in Benelux, France, Germany, North America, Nordic countries, the United Kingdom, Ireland and internationally. Eurofins Scientific SE is headquartered in Luxembourg. | |||